Page 468 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 468

ChaPTEr 31  Immune Responses to Helminth Infection                 447


           vaccine candidates: (i) S. hematobium Sh28GST (phase II); (ii)   18.  Anthony RM, Rutitzky LI, Urban JF Jr, et al. Protective immune
           S. mansoni Sm-TSP-2 (phase I); (iii) S. mansoni Sm-14 (phase   mechanisms in helminth infection. Nat Rev Immunol 2007c;7:
           I); and two hookworm vaccine candidates: (i) Na-GST-1 (phase   975–87.
           I);  (ii) Na-APR-1 (phase I). In addition, the two  O. volvulus   19.  Finkelman FD, Shea-Donohue T, Goldhill J, et al. Cytokine regulation of
           vaccine candidates—Ov-103 and Ov-RAL2—and the S. mansoni   host defense against parasitic gastrointestinal nematodes: lessons from
                                                                    studies with rodent models. Annu Rev Immunol 1997;15:505–33.
           candidate—Sm-p80—are in preclinical testing.  With rapid   20.  Zandman-Goddard G, Shoenfeld Y. Parasitic infection and autoimmunity.
           advances in the parasite genomics and proteomics, as well the   Lupus 2009;18:1144–8.
           newer, better vaccine delivery systems offering more efficient   21.  Wynn TA, Thompson RW, Cheever AW, et al. Immunopathogenesis of
           and quicker assessment, the prospects for newer anthelmintic   schistosomiasis. Immunol Rev 2004;201:156–67.
           vaccines are excellent, although the potential lack of commercial   22.  Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid repair response
           markets imposes a significant impediment to their development.  to tissue destructive pathogens. PLoS Pathog 2011;7:e1002003.
                                                                  23.  Pfarr KM, Debrah AY, Specht S, et al. Filariasis and lymphoedema.
           Please check your eBook at https://expertconsult.inkling.com/   Parasite Immunol 2009;31:664–72.
           for self-assessment questions. See inside cover for registration   24.  Pritchard DI. The pro-allergic influences of helminth parasites. Mem Inst
           details.                                                 Oswaldo Cruz 1997;92:15–18.
                                                                  25.  Gause WC, Wynn TA, Allen JE. Type 2 immunity and wound healing:
                                                                    evolutionary refinement of adaptive immunity by helminths. Nat Rev
           REFERENCES                                               Immunol 2013;13:607–14.
                                                                  26.  Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and
           1.  Keusch GT. Immune responses in parasitic diseases. Part A: general   fibrosis. Immunity 2016;44:450–62.
             concepts. Rev Infect Dis 1982;4:751–5.               27.  Babu S, Nutman TB. Immunopathogenesis of lymphatic filarial disease.
           2.  Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths.   Semin Immunopathol 2012;34:847–61.
             Nat Rev Immunol 2011;11:375–88.                      28.  Fried B, Reddy A, Mayer D. Helminths in human carcinogenesis. Cancer
           3.  Mishra PK, Palma M, Bleich D, et al. Systemic impact of intestinal   Lett 2011;305:239–49.
             helminth infections. Mucosal Immunol 2014;7:753–62.  29.  Harnett W, Harnett MM. Helminth-derived immunomodulators: can
           4.  Hammad H, Lambrecht BN. Barrier Epithelial cells and the control of   understanding the worm produce the pill? Nat Rev Immunol
             type 2 immunity. Immunity 2015;43:29–40.               2010;10:278–84.
           5.  McKenzie AN, Spits H, Eberl G. Innate lymphoid cells in inflammation   30.  Hewitson JP, Grainger JR, Maizels RM. Helminth immunoregulation: the
             and immunity. Immunity 2014;41:366–74.                 role of parasite secreted proteins in modulating host immunity. Mol
           6.  Kreider T, Anthony RM, Urban JF Jr, et al. Alternatively activated   Biochem Parasitol 2009;167:1–11.
             macrophages in helminth infections. Curr Opin Immunol   31.  Smith P, Fallon RE, Mangan NE, et al. Schistosoma mansoni secretes a
             2007;19:448–53.                                        chemokine binding protein with antiinflammatory activity. J Exp Med
           7.  Grencis RK. Immunity to helminths: resistance, regulation, and   2005;202:1319–25.
             susceptibility to gastrointestinal nematodes. Annu Rev Immunol   32.  Coakley G, Buck AH, Maizels RM. Host parasite
             2015;33:201–25.                                        communications-Messages from helminths for the immune system. Mol
           8.  Noelle RJ, Nowak EC. Cellular sources and immune functions of   Biochem Parasitol 2016;208:33–40.
             interleukin-9. Nat Rev Immunol 2010;10:683–7.        33.  Belkaid Y, Tarbell K. Regulatory T cells in the control of
           9.  Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol   host-microorganism interactions. Annu Rev Immunol 2009;27:551–89.
             2011;29:621–63.                                      34.  Everts B, Smits HH, Hokke CH, et al. Helminths and dendritic cells:
           10.  Larkin BM, Smith PM, Ponichtera HE, et al. Induction and regulation of   sensing and regulating via pattern recognition receptors, Th2 and Treg
             pathogenic Th17 cell responses in schistosomiasis. Semin Immunopathol   responses. Eur J Immunol 2010;40:1525–37.
             2012;34:873–88.                                      35.  Gause WC, Maizels RM. Macrobiota—helminths as active participants
           11.  Bouchery T, Kyle R, Ronchese F, et al. The differentiation of CD4(+)   and partners of the microbiota in host intestinal homeostasis. Curr Opin
             T-helper Cell subsets in the context of helminth parasite infection. Front   Microbiol 2016;32:14–18.
             Immunol 2014;5:487.                                  36.  Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the
           12.  Shen P, Fillatreau S. Antibody-independent functions of B cells: a focus   hygiene hypothesis. Science 2002;296:490–4.
             on cytokines. Nat Rev Immunol 2015;15:441–51.        37.  Wilson MS, Maizels RM. Regulation of allergy and autoimmunity in
           13.  Harris N, Gause WC. To B or not to B: B cells and the Th2-type immune   helminth infection. Clin Rev Allergy Immunol 2004;26:35–50.
             response to helminths. Trends Immunol 2011;32:80–8.  38.  Fleming JO, Weinstock JV. Clinical trials of helminth therapy in
           14.  Klion AD, Nutman TB. The role of eosinophils in host defense against   autoimmune diseases: rationale and findings. Parasite Immunol
             helminth parasites. J Allergy Clin Immunol 2004;113:30–7.  2015;37:277–92.
           15.  Karasuyama H, Mukai K, Obata K, et al. Nonredundant roles of basophils   39.  Bethony JM, Cole RN, Guo X, et al. Vaccines to combat the neglected
             in immunity. Annu Rev Immunol 2011;29:45–69.           tropical diseases. Immunol Rev 2011;239:237–70.
           16.  Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and   40.  Hotez PJ, Strych U, Lustigman S, et al. Human anthelminthic vaccines:
             regulatory cells in innate and adaptive immunity. Eur J Immunol   Rationale and challenges. Vaccine 2016;34:3549–55.
             2010;40:1843–51.
           17.  Allen JE, Sutherland TE, Ruckerl D. IL-17 and neutrophils: unexpected
             players in the type 2 immune response. Curr Opin Immunol
             2015;34:99–106.
   463   464   465   466   467   468   469   470   471   472   473